In vitro activity of the New Echinocandin Antifungal, MK-0991, against common and uncommon clinical isolates of Candida species

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 4, 1999, Pages 302-304

  Barchiesi, F ^a   Schimizzi, A M ^a   Fothergill, A W ^b   Scalise, G ^a   Rinaldi, M G ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE;

ARTICLE; CANDIDA; CONTROLLED STUDY; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; YEAST;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC;

EID: 0032704707     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050283     Document Type: Article

References (15)

1. 1. Ngyuen MH, Peacock JE Jr, Morris AJ: The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. American Journal of Medicine (1996) 100:617-623
2. 2. Rex JH, Rinaldi MG, Pfaller MA: Resistance of Candida species to fluconazole. Antimicrobial Agents and Chemotherapy (1995) 38:1-8
3. 3. Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine (1994) 330:263-272
4. 4. Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G: Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. Journal of Antimicrobial Chemotherapy (1998) 41:541-548
5. 5. Denning DW: Echinocandins and pneumocandins - a new antifungal class with a novel model of action. Journal of Antimicrobial Chemotherapy (1997) 40:611-614
6. 6. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Balkovec JM, Bouffard AF, Dropinski JF, Rosen H, Kropp H, Bartizal K: Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and Chemotherapy (1997) 41:2333-2338
7. 7. Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, Scott PM, Smith JG, Leighton CE, Bouffard A, Dropinski JF, Balkovec J: In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy (1997) 41:2326-2332
8. 8. Del Poeta M, Schell WA, Perfect JR: In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrobial Agents and Chemotherapy (1997) 41:1835-1836
9. 9. Graybill JR, Bocanegra R, Luther M, Fothergill A, Rinaldi MG: Treatment of murine Candida krusei or Candida glabrata infection with L-743,872. Antimicrobial Agents and Chemotherapy (1997) 41:1937-1939
10. 10. Graybill JR, Najvar LK, Luther MF, Fothergill AW: Treatment of murine disseminated candidiasis with L-743,872. Antimicrobial Agents and Chemotherapy (1997) 41:1775-1777
11. 11. Graybill JR, Najvar LK, Montalbo EM, Barchiesi F, Luther MF, Rinaldi MG: Treatment of histoplasmosis with MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy (1998) 42:151-153
12. 12. Vazquez JA, Lynch M, Boikov D, Sobel JD: In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species. Antimicrobial Agents and Chemotherapy (1997) 41:1612-1614
13. 13. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. M27-A. NCCLS, Wayne, PA (1997)
14. 14. Shadomy S, Pfaller MA: Laboratory studies with antifungal agents: susceptibility tests and quantitation in body fluids. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ (eds): Manual of clinical microbiology. American Society for Microbiology, Washington, DC (1991) pp 1173-1183
15. 15. Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, Kropp H: Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy (1997) 41:2339-2344